Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
About Investor
Matthew Buten is Chief Financial Officer at Biohaven Pharmaceuticals and invests as an Advisor (previously an investor at AlleyCorp). His investing focus is healthcare across Consumer Health, BioTech, Digital Health, Health IT, and Health & Hospital Services, typically from Seed through Series B, with an investment range of $100K–$5.0M. Earlier in his career, he was a Managing Director at Foresite Capital and also worked as an investment banking advisor in healthcare.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.